Answer
As a precaution, it is preferable to avoid erenumab (Aimovig) during pregnancy, because data in pregnant women are limited, although animal studies do not indicate direct or indirect harmful effects on reproduction.
Sources for this answer
- Aimovig solution for injection in pre filled penNovartis Pharmaceuticals UK Ltd · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 12Document updated
Sources checked